Food comas are a common experience—here's what can trigger them (and how to prevent them). Medically reviewed by Jessica ...

Despite recent stock underperformance, Neurocrine's Ingrezza and promising pipeline make it a buying opportunity for ...

Recent studies have suggested that dopamine agonists (DAs), widely used in Parkinson's disease (PD) management, might increase the risk of sudden uncontrollable somnolence. Avorn et al.

“If someone decides to try it, I would recommend to start with a low daily dose (50 milligrams maximum) and make sure to monitor themselves for side effects like somnolence (drowsiness), fatigue ...

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of ...

Anavex faces challenges with failed drug trials, operational risks, and questionable decisions, leading to a strong sell ...

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and ...

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367) in Japan evaluating the safety and efficacy of EFFEXOR® (venlafaxine ...

Indiana is fortunate to be a compact state. Most rural counties are within an easy commute to a metropolitan county. Still, ...

The answer is not yet known. Researchers continue to study how sleep might affect cancer risk. Some studies suggest that the risk of cancer may increase when there are chronic sleep problems. This ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for rare diseases, is pleased to announce ...